District of Columbia – Stock Epinephrine Law
On January 12, 2016, the DC Council enacted DC Act 21-259, “Access to Emergency Epinephrine in Schools Amendment Act of 2015”, which authorizes public schools to possess and administer epinephrine injectors and to require the Office of the State Superintendent of Education to establish and administer an undesignated epinephrine auto-injector plan; and to amend the District of Columbia Health Occupations Revision Act of 1985 and the State Education Office Establishment Act of 2000 to make conforming amendments.
Allergy & Asthma Network supports stock epinephrine legislation as well as implementation in schools and provides education and resources to support a seamless rollout. For more information, visit:
- 2016 USAnaphylaxis Summits
- Challenges to Implementing Stock Epinephrine
- National Association of School Nurses Epinephrine Policies, Protocols, and Reporting
Autumn Burnette, MD
Board-certified Allergist and Assistant Professor in the Division of Allergy and Clinical Immunology
Daniel Ein, MD
GW Medical Faculty Associates
On July 27, 2015, Dr. Autumn Burnette was interviewed about the new possible cure for peanut allergies on WJLA-Washington, DC. Approximately 150,000 viewers watched the interview.
Questions about state legislation, ACE activities or getting involved?
About Anaphylaxis Community Experts (ACEs):
Anaphylaxis Community Experts is a national, award-winning education, advocacy and outreach partnership program developed and hosted by The Network and the American College of Allergy, Asthma & Immunology, sponsored by Mylan Specialty L.P.